Stop by the Haemonetics booth at the AABB 2020 Virtual Annual Meeting
Discover our market leading technologies and value beyond the technology.
Blood Centers
We offer products and services to help ensure blood safety, improve operational efficiency and collect the blood components in the greatest demand.
Plasma Centers
We advance technologies that enable higher plasma yield collections, improve productivity in our customers’ centers, and enhance the overall donor experience.
Hospitals
We provide innovative solutions that enable healthcare professionals to improve patient care and economic outcomes in critical settings.
Connect with us to learn more
Featured Technology
SafeTrace Tx® Transfusion Management Software
Designed by blood bankers.
For blood bankers.
With your needs in mind.
BloodTrack® Blood Management and Bedside Transfusion Software
Enhance safety.
Maintain traceability.
Reduce waste.
Cell Saver® Elite®+ Autologous Blood Recovery System
Performance you can count on – because patients are counting on you.
Stay current with this year's educational program
As our industry faces unprecedented times, AABB continues to offer a robust and relevant educational line up that supports the industry's current challenges. Haemonetics remains committed to supporting AABB’s program and we look forward to connecting and collaborating at the virtual meeting. This year we are pleased to sponsor the following educational sessions:
Saturday, October 3rd
9:00 am - 9:45 am
Workshop Zoom Room 1
Topic 1: Viscoelastic Testing Plays an Integral Role in PBM Program
Presenter: Steven Frank, MD, Director Johns Hopkins Health System Blood Management Program, Johns Hopkins Hospital
Topic 2: The Use of Thromboelastography for Peri-Operative Coagulation and Blood Product Management in Cardiac Surgery - Our Journey
Presenter: Michael Moront, MD, FACS, Director, Cardiac Surgical Research ProMedica Health Systems
Sunday, October 4th
6:00 pm - 7:00 pm
Virtual Room 1
Topic: PL1-AM20-31: Use of a Novel, Personalized Nomogram to Optimize Plasma Collection Yields without Increasing Adverse Event Rates: Results from IMPACT, a Randomized Controlled Trial of 23,137 Donations
Presenter: Jan Hartmann, MD, Vice President Medical Affairs, Haemonetics
Explore the full program here.
Any questions, email events@haemonetics.com